Immediate Impact
7 standout
Citing Papers
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
Targeting cytokine and chemokine signaling pathways for cancer therapy
2024 Standout
Works of Zachary Lee being referenced
Phase I Study Protocol: NKTR-255 as Monotherapy or Combined with Daratumumab or Rituximab in Hematologic Malignancies
2021
957 NKTR-255+cetuximab in patients with solid tumors: interim safety and efficacy results from the phase 1b dose-escalation study
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Zachary Lee | 30 | 32 | 39 | 17 | 115 | |
| Joseph H. Oved | 45 | 49 | 30 | 32 | 166 | |
| Christian Sauter | 31 | 17 | 55 | 23 | 178 | |
| Sampara Vasishta | 26 | 20 | 73 | 14 | 172 | |
| Zoë C. Wong | 20 | 28 | 45 | 13 | 190 | |
| Yongqiang Deng | 23 | 47 | 89 | 19 | 181 | |
| Poornachander R. Guda | 11 | 16 | 85 | 13 | 145 | |
| Chunrun Qu | 60 | 32 | 68 | 15 | 196 | |
| Michelle Schweiger | 47 | 34 | 71 | 14 | 189 | |
| Cheryl Goss | 29 | 10 | 21 | 15 | 184 | |
| Xianqun Xu | 46 | 22 | 107 | 15 | 207 |
All Works
Login with ORCID to disown or claim papers
Loading papers...